Bestsellers

Track Order

Generic Norvasc 2.5 mg	per pill, us $	price, us $	order
2.5mg × 30	0.86	25.70
2.5mg × 60	0.75	44.99
2.5mg × 90	0.64	57.85
2.5mg × 300	0.56	167.19

Generic Norvasc 5 mg	per pill, us $	price, us $	order
5mg × 30	1.18	35.35
5mg × 60	1.07	64.29
5mg × 90	0.96	86.80
5mg × 100	1.03	102.88

Generic Norvasc 10 mg	per pill, us $	price, us $	order
10mg × 10	2.70	26.96
10mg × 20	1.77	35.35
10mg × 30	1.18	35.35
10mg × 60	1.07	64.29
10mg × 90	0.86	77.15
10mg × 100	0.87	86.80
10mg × 200	0.51	102.88
10mg × 300	0.57	170.40

More product info »

Accupril Aggrenox Altace Betapace Calan Capoten Cardizem Cardizem Cd Cardizem Cr Cardizem Er Cartia Cartia Cd Cartia Cr Cartia Er Cordarone Coreg Covera Hs Diamox Digitek Dilacor Dilacor Cd Dilacor Cr Dilacor Er Diltia Diltia Cd Diltia Cr Diltia Er Diltiazem Diltiazem Cd Diltiazem Cr Diltiazem Xl Diovan Enalapril Inderal Inderal La Isordil Sublingual Isordil Titradose Isordil Titradose Tr Lanoxin Lopressor Lotensin Lotrel Mexitil Micardis Hct Monoket Monopril Nebilet Nimotop Norvasc Oretic Pacerone Plavix Plendil Prevacid Procardia Reglan Sorbitrate Sorbitrate Tr Tenoretic Tenormin Tiazac Tiazac Cd Tiazac Cr Tiazac Er Tiazac Xl Ticlid Toprol Vasotec Verelan Sr Zantac Ziac Zocor

search

Bonus: FREE sample pills for our buyers

You can get FREE sample tablets (Erectile dysfunction medication) with your order. Just buy ED drugs (60 or more pills) and choose 4 Viagra pills or 2 Cialis pills as a free bonus from our drugstore.

Our Special Offer :

Check the status of your order

Last News
of World Medicine

Once-Weekly Diabetes Treatment Gets FDA OK

WASHINGTON -- The delay is over for the diabetes drug Bydureon (exenatide extended-release), with FDA approval making it the first once-weekly treatment for type 2 disease.

FDA OKs Axitinib for Kidney Cancer

Another angiogenesis blocker, axitinib (Inlyta), has won FDA approval as a second-line treatment for advanced kidney cancer, the agency said Friday.

Federal Injunction Blocks Ranbaxy from Marketing in U.S.

WASHINGTON --The Justice Department filed a consent decree today preventing generic drug giant Ranbaxy from selling drugs made at four of its manufacturing plants until it brings them into compliance with the FDA's quality standards.

Our Billing is Certified by :

0.00 (0 items)

Website design Bestsellers News Testimonial FAQ Contact Track Order About PharmORBIT drugstore Affilate